Literature DB >> 15313196

Interleukin-6 regulates hepatic transporters during acute-phase response.

Elmar Siewert1, Christoph G Dietrich, Frank Lammert, Peter C Heinrich, Siegfried Matern, Carsten Gartung, Andreas Geier.   

Abstract

Cholestasis develops during inflammatory conditions characterized by the release of cytokines like interleukin-6 (IL-6), which is the major player in the hepatic acute-phase response. However, the exact contribution of IL-6 to transporter down-regulation is unclear. Therefore, we compared wild-type and IL-6-deficient mice after IL-6-injection and induction of an aseptic (turpentine-injection) or septic (LPS-injection) acute-phase response. Down-regulation of basolateral (Ntcp, Oatp1, and Mrp3) and canalicular (Mrp2, Bsep) transporter mRNA occurred after treatment with IL-6, turpentine, and LPS. In IL-6-deficient mice, turpentine failed to decrease mRNA-levels of basolateral and canalicular transporters, whereas LPS-mediated down-regulation of Ntcp, Mrp3, and Mrp2 was abolished at later time points (24 h). In conclusion, induction of an aseptic and septic acute-phase response leads to the down-regulation of basolateral and canalicular organic anion transporters. IL-6 is required for transporter down-regulation during aseptic inflammation. Furthermore, IL-6 also contributes to transporter regulation during LPS-induced cholestasis at more delayed time points.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313196     DOI: 10.1016/j.bbrc.2004.07.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

2.  Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response.

Authors:  Juan P Liuzzi; Louis A Lichten; Seth Rivera; Raymond K Blanchard; Tolunay Beker Aydemir; Mitchell D Knutson; Tomas Ganz; Robert J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-29       Impact factor: 11.205

Review 3.  The Multiple Faces of the Metal Transporter ZIP14 (SLC39A14).

Authors:  Tolunay B Aydemir; Robert J Cousins
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

Review 4.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

5.  Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}.

Authors:  Lei Diao; Na Li; Timothy G Brayman; Kathy J Hotz; Yurong Lai
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

6.  Microarray analysis of distinct gene transcription profiles in non-eosinophilic chronic sinusitis with nasal polyps.

Authors:  Spencer C Payne; Joseph K Han; Phillip Huyett; Julie Negri; Elizabeth Z Kropf; Larry Borish; John W Steinke
Journal:  Am J Rhinol       Date:  2008 Nov-Dec

Review 7.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

Review 8.  Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

Authors:  Carol J Soroka; James L Boyer
Journal:  Mol Aspects Med       Date:  2013-05-15

9.  IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.

Authors:  Kenneth M Andrejko; Nichelle R Raj; Patrick K Kim; Maurizio Cereda; Clifford S Deutschman
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

Review 10.  The SLC39 family of zinc transporters.

Authors:  Jeeyon Jeong; David J Eide
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.